Stay updated on GRN-1201 & Pembrolizumab in Metastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the GRN-1201 & Pembrolizumab in Metastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GRN-1201 & Pembrolizumab in Metastatic NSCLC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-28T19:57:24.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-21T20:48:48.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.1 to v3.7.2 on the ClinicalTrials.gov error page.
    Difference
    0.2%
    Check dated 2026-10-14T20:50:45.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.0 to v3.7.1 while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T21:35:36.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with a minimal header and a Home link. The previous study record content appears to be removed or hidden.
    Difference
    18%
    Check dated 2026-09-23T21:42:15.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    A new page revision v3.7.0 is added and the previous revision v3.6.6 is removed, signaling an update to the page version.
    Difference
    0.1%
    Check dated 2026-09-16T21:36:50.000Z thumbnail image

Stay in the know with updates to GRN-1201 & Pembrolizumab in Metastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GRN-1201 & Pembrolizumab in Metastatic NSCLC Clinical Trial page.